Pfizer
-
Pfizer Pushes for 4th COVID-19 Vaccine Dose: Is This for Life After the Pandemic?
-
Pfizer 4th COVID-19 Vaccine Shot Data: Findings Show Booster's Efficiency Disappears After Four Months
-
Free COVID Antiviral Pills to Roll Out in the US | Here's Everything You Need to Know About 'Test to Treat' Program
-
COVID-19 Pill: Asks for More Payment, Threatens Access—Does it Mean it Will be More Expensive?
-
Pfizer COVID Vaccine: FDA Approval for Use on Children Ages 6 Mos. to 4 Years Old Now Processing
-
Omicron-Specific Pfizer Vaccine's Clinical Trials Begin To Test Efficiency and Safety
-
Pfizer COVID-19 Pill Paxlovid Gets FDA Authorization, But How Effective Is It?
-
Pfizer, Moderna to ‘Update’ Vaccines to Work Against New Extremely Infectious Variants, WHO Warns
-
Cheap Pfizer COVID-19 Pill? New Licensing Agreement to Allow Generic-Drug Makers to Produce the Medicine
-
Pfizer COVID-19 Booster Shots to Ask for FDA Approval for Adults—Is it Available for ‘Mix and Match’?
-
Pfizer Says Its COVID-19 Pill Reduces Risk of Hospitalization and Death by 89%
-
COVID-19 Vaccine for Kids 5 to 11 Gets FDA Approval for EUA, May Begin in the Coming Weeks
Most Popular
